APA

Schneider B. J., Worden F. P., Gadgeel S. M., Parchment R. E., Hodges C. M., Zwiebel J., Dunn R. L., Wozniak A. J., Kraut M. J. & Kalemkerian G. P. (20130419). Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer. : Investigational new drugs.

Chicago

Schneider Bryan J, Worden Francis P, Gadgeel Shirish M, Parchment Ralph E, Hodges Collette M, Zwiebel James, Dunn Rodney L, Wozniak Antoinette J, Kraut Michael J and Kalemkerian Gregory P. 20130419. Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer. : Investigational new drugs.

Harvard

Schneider B. J., Worden F. P., Gadgeel S. M., Parchment R. E., Hodges C. M., Zwiebel J., Dunn R. L., Wozniak A. J., Kraut M. J. and Kalemkerian G. P. (20130419). Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer. : Investigational new drugs.

MLA

Schneider Bryan J, Worden Francis P, Gadgeel Shirish M, Parchment Ralph E, Hodges Collette M, Zwiebel James, Dunn Rodney L, Wozniak Antoinette J, Kraut Michael J and Kalemkerian Gregory P. Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer. : Investigational new drugs. 20130419.